Genomic HLA heterozygosity as a predictive marker for survival in lung cancer patients post immunotherapy

A. Abed, Adnan Khattak, M. Millward, A. Chopra, E. Gray

    Research output: Contribution to journalAbstract/Meeting Abstractpeer-review

    Original languageEnglish
    Article numberLBA14
    Number of pages1
    JournalAnnals of Oncology
    Issue numberSupplement 9
    Publication statusPublished - Nov 2019
    EventEuropean-Society-for-Medical-Oncology (ESMO) Asia Congress - Singapore, Singapore
    Duration: 22 Nov 201924 Nov 2019

    Cite this